Skip to content
Cytognos S.L. Logo Cytognos S.L. Logo
  • PRODUCTS
    • Product lines
      • Antibodies
      • Multicolor
      • Next Generation Flow™
      • Ancillary Reagents
      • Flow Cytometer
      • Software
    • NGF Solutions by EuroFlow™
      • Acute Leukemia
      • Chronic Lymphoproliferative Disorders
      • Plasma Cell Dyscrasias
      • Primary Immunodeficiencies
    • Omnicyt™

      Flow
      Cytometer

    • Infinicyt™

      Flow
      Cytometry Software

    • Euroflow™ Databases

      Automated
      Data Analysis

  • CONTACT & SUPPORT
  • COMPANY
    • About Us
    • Distributed Products
    • Catalog 2019
    • Work with us
  • EVENTS
  • ACADEMY
    • Chronic Lymphoproliferative Disorders
    • Acute Leukemia
    • Plasma Cell Dyscrasias
    • Primary Immunodeficiencies
    • Cytognos technology
      • EuroFlow™
      • Flow Cytometry
      • Software
  • en
  • es
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in products
    Search in pages
    Search in products

Cytognos technology

Home/Academy/Cytognos technology
Cytognos technologycyt-cytouser2019-06-13T08:38:09+01:00
  • Chronic Lymphoproliferative Disorders
    • Description
    • Evaluation of disease
    • Treatment
  • Acute Leukemia
    • Description
    • Evaluation of disease
    • Treatment
    • MRD assessment
  • Plasma Cell Dyscrasias
    • Description
    • Evaluation of disease
    • Treatment
    • MRD assessment
    • What are Circulating Tumor Plasma Cells?
  • Primary Immunodeficiencies
    • Description
    • Evaluation of the disease
    • Treatment
    • Immune Monitoring
  • Cytognos technology
    • EuroFlow™
      • Description
      • The EuroFlow™ SOPs
      • The EuroFlow™ workflow
        • Oncohematology panels
        • Immunology panels
    • Flow Cytometry
      • What is flow cytometry?
      • What is an antibody?
      • Applications of flow cytometry
      • The flow cytometer
        • Acoustic foccusing
    • Software
      • Multiparametric analysis of flow cytometry data
      • Clustering
      • Automated analysis

Our products

NGF solutions
EuroFlow™ reagents
Acute Leukemia
Chronic Lymphoproliferative Disorders
Plasma Cell Dyscrasias
Primary Immunodeficiencies
Omnicyt™
Infinicyt™

Summary on the use of your data

Cytognos recognizes the importance of protecting your personal information and is committed to processing it responsibly and in compliance with applicable data protection laws.

  • Responsable: Cytognos, S.L.
  • Purpose: manage and answer your enquiries, send you direct marketing related to Cytognos products and services..
  • Legitimation: you give your consent by selecting the Privacy Policy's checkbox.
  • Period of maintenance of your data: while you interact with us and until you unsubscribe from our informative communications and direct marketing.
  • Recipients: we may share your personal data with our professional advisors. We can also share your data with government authorities if required by law or in case it is necessary for the protection of our legitimate interest in compliance with applicable laws.
  • Rights: you have the right of access, rectification, deletion, portability of your data, as well as the right to limitation, opposition to treat or withdrawal of consent for processing your personal data.

Please go to Privacy Policy.

The company

About us
Contact & Support
Events
Work with us
Projects

Useful information

EuroFlow™
Cytognos technology
Minimal Residual Disease
Clinical trials
Scheduled webinars

Legal Notice

Legal Notice
Terms of use
Privacy Policy
Cookie Policy
Terms and Conditions of Sale
Anti-corruption Policy

Cytognos, S.L. complies with ISO 9001:2015 Quality Management and ISO 13485:2016 for the design, development, production and sale of antibodies and flow cytometry kits for In Vitro products and research. Cytognos S.L. products for In Vitro Diagnostic comply with Directive 98/79/EC.

Copyright © 2019 Cytognos S.L.. All Rights Reserved.

All products listed are labeled with some regulatory status as per indicated below:
“RUO” or “For Research Use Only”: not intended for diagnostic or therapeutic procedures.
“IVD” or “In Vitro Diagnostic” and including the “CE” (Conformité Européenne) marking: intended for In Vitro Diagnostic use within the European Union and countries with EU conformity recognition agreement.
“LUO” or “Laboratory Use Only”: general purpose laboratory reagents.
“ASR” or “Analyte Specific Reagent”: reagents in which the analytical and performance characteristics are not established. ASRs are regulated by the US Food and Drug Administration (FDA).

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set.
To find out more about the cookies we use and how to delete them, see our Cookie Policy.
Agree
preloader